QA: Intelgenx Technologies Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2022_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 11,437,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,213,000
3 remainder_Assets 1,255,000
4 LiabilitiesCurrent 7,020,000
5 LiabilitiesNoncurrent 642,000
6 remainder_Liabilities 6,372,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,585,379
9 ResearchAndDevelopmentExpense 2,717,796
10 remainder_Expenses 2,811,163
11 remainder_Revenues 1,532,529
12 remainder_NetIncome -1,207,328
13 remainder_ComprehensiveNetIncome -324,334
  yvar yval
0 Assets 17,905,000
1 Liabilities 14,034,000
2 Expenses 9,114,338
3 Revenues 1,532,529
4 StockholdersEquity 3,871,000
5 NetIncome -8,789,137
6 ComprehensiveNetIncome -8,951,304
7 BaseVar 22,058,764
8 EconomicCapitalRatiobeforeLimitedLiability -0.0321
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time